ProPhase Labs, Inc. Marketing and Advertising Expense
ProPhase Labs, Inc. (PRPH) reported Marketing and Advertising Expense of $443.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2020-03-26
- ProPhase Labs, Inc. marketing and advertising expense for the quarter ending 2019-12-31 was $91.00K, a 57.28% decline year-over-year.
- ProPhase Labs, Inc. marketing and advertising expense for the quarter ending 2019-09-30 was $270.00K, a 1828.57% increase year-over-year.
- ProPhase Labs, Inc. marketing and advertising expense for the quarter ending 2019-06-30 was $55.00K, a 41.03% increase year-over-year.
- ProPhase Labs, Inc. marketing and advertising expense for the quarter ending 2019-03-31 was $27.00K, a 440.00% increase year-over-year.
- ProPhase Labs, Inc. marketing and advertising expense for fiscal 2019 was $443.00K, a 67.80% increase from fiscal 2018.
- ProPhase Labs, Inc. marketing and advertising expense for fiscal 2018 was $264.00K.
- ProPhase Labs, Inc. marketing and advertising expense for fiscal 2016 was $9.70M, a 14.12% increase from fiscal 2015.
- ProPhase Labs, Inc. marketing and advertising expense for fiscal 2015 was $8.50M, a 22.02% decline from fiscal 2014.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 3 month as first filed | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 6 month as first filed | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 9 month as first filed | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $361.00K derived: sum of 2 quarters · filed 2020-03-26 | $416.00K derived: sum of 3 quarters · filed 2020-03-26 | $443.00K 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $270.00K 10-Q · filed 2019-11-12 | $325.00K derived: sum of 2 quarters · filed 2019-11-12 | $352.00K 10-Q · filed 2019-11-12 | $565.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2019-06-30 | $55.00K 10-Q · filed 2019-08-12 | $82.00K 10-Q · filed 2019-08-12 | $295.00K derived: sum of 3 quarters · filed 2020-03-26 | $309.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2019-03-31 | $27.00K 10-Q · filed 2019-05-14 | $240.00K derived: sum of 2 quarters · filed 2020-03-26 | $254.00K derived: sum of 3 quarters · filed 2020-03-26 | $293.00K derived: sum of 4 quarters · filed 2020-03-26 | |||
| 2018-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $227.00K derived: sum of 2 quarters · filed 2020-03-26 | $266.00K derived: sum of 3 quarters · filed 2020-03-26 | $264.00K 10-K · filed 2020-03-26 | |||
| 2018-09-30 | $14.00K 10-Q · filed 2019-11-12 | $53.00K derived: sum of 2 quarters · filed 2019-11-12 | $51.00K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $39.00K 10-Q · filed 2019-08-12 | $72.00K 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | $5.00K 10-Q · filed 2019-05-14 | ||||||
| 2017-09-30 | $22.00K 10-Q/A · filed 2018-08-20 | $43.00K derived: sum of 2 quarters · filed 2018-08-20 | $78.00K 10-Q/A · filed 2018-08-20 | $9.39M derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2017-06-30 | $21.00K 10-Q/A · filed 2018-08-20 | $53.00K 10-Q/A · filed 2018-08-20 | $9.37M derived: sum of 3 quarters · filed 2018-08-20 | $9.41M derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2017-03-31 | $32.00K 10-Q/A · filed 2018-08-20 | $9.35M derived: sum of 2 quarters · filed 2018-08-20 | $9.39M derived: sum of 3 quarters · filed 2018-08-20 | $9.53M derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2016-12-31 | $9.31M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-02-24 | $9.36M derived: sum of 2 quarters · filed 2018-08-20 | $9.50M derived: sum of 3 quarters · filed 2018-08-20 | $9.70M 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $46.00K 10-Q/A · filed 2018-08-20 | $1.20M 10-Q · filed 2016-11-14 | $185.00K derived: sum of 2 quarters · filed 2018-08-20 | $385.00K 10-Q/A · filed 2018-08-20 | $5.10M 10-Q · filed 2016-11-14 | $4.68M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2016-06-30 | $139.00K 10-Q/A · filed 2018-08-20 | $694.00K 10-Q · filed 2016-08-11 | $339.00K 10-Q/A · filed 2018-08-20 | $3.80M 10-Q · filed 2016-08-11 | $4.64M derived: sum of 3 quarters · filed 2018-08-20 | $5.28M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2016-03-31 | $199.00K 10-Q/A · filed 2018-08-20 | $3.10M 10-Q · filed 2016-05-13 | $4.50M derived: sum of 2 quarters · filed 2018-08-20 | $5.14M derived: sum of 3 quarters · filed 2018-08-20 | $5.59M derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2015-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.95M derived: sum of 2 quarters · filed 2017-02-24 | $5.39M derived: sum of 3 quarters · filed 2017-02-24 | $8.50M 10-K · filed 2017-02-24 | |||
| 2015-09-30 | $645.00K 10-Q · filed 2016-11-14 | $1.09M derived: sum of 2 quarters · filed 2016-11-14 | $4.20M 10-Q · filed 2016-11-14 | $9.39M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | $442.00K 10-Q · filed 2016-08-11 | $3.60M 10-Q · filed 2016-08-11 | $8.74M derived: sum of 3 quarters · filed 2017-02-24 | $10.04M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $3.10M 10-Q · filed 2016-05-13 | $8.30M derived: sum of 2 quarters · filed 2017-02-24 | $9.60M derived: sum of 3 quarters · filed 2017-02-24 | $10.70M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $6.50M derived: sum of 2 quarters · filed 2017-02-24 | $7.60M derived: sum of 3 quarters · filed 2017-02-24 | $10.90M 10-K · filed 2017-02-24 | |||
| 2014-09-30 | $1.30M 10-Q · filed 2015-11-13 | $2.40M derived: sum of 2 quarters · filed 2015-11-13 | $5.70M 10-Q · filed 2015-11-13 | $10.70M derived: sum of 4 quarters · filed 2016-03-29 | |||
| 2014-06-30 | $1.10M 10-Q · filed 2015-08-12 | $4.50M 10-Q · filed 2015-08-12 | $9.40M derived: sum of 3 quarters · filed 2016-03-29 | $10.80M derived: sum of 4 quarters · filed 2016-03-29 | |||
| 2014-03-31 | $3.40M 10-Q · filed 2015-05-13 | $8.30M derived: sum of 2 quarters · filed 2016-03-29 | $9.70M derived: sum of 3 quarters · filed 2016-03-29 | $10.23M derived: sum of 4 quarters · filed 2016-03-29 | |||
| 2013-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $6.30M derived: sum of 2 quarters · filed 2016-03-29 | $6.83M derived: sum of 3 quarters · filed 2016-03-29 | $10.80M 10-K · filed 2016-03-29 | |||
| 2013-09-30 | $1.40M 10-Q · filed 2014-11-13 | $1.93M derived: sum of 2 quarters · filed 2014-11-13 | $5.90M 10-Q · filed 2014-11-13 | $10.53M derived: sum of 4 quarters · filed 2015-03-27 | |||
| 2013-06-30 | $527.00K 10-Q · filed 2014-08-12 | $4.40M 10-Q · filed 2014-08-12 | $9.13M derived: sum of 3 quarters · filed 2015-03-27 | $10.43M derived: sum of 4 quarters · filed 2015-03-27 | |||
| 2013-03-31 | $3.90M 10-Q · filed 2014-05-12 | $8.60M derived: sum of 2 quarters · filed 2015-03-27 | $9.90M derived: sum of 3 quarters · filed 2015-03-27 | $10.58M derived: sum of 4 quarters · filed 2015-03-27 | |||
| 2012-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $6.00M derived: sum of 2 quarters · filed 2015-03-27 | $6.68M derived: sum of 3 quarters · filed 2015-03-27 | $10.20M 10-K · filed 2015-03-27 | |||
| 2012-09-30 | $1.30M 10-Q · filed 2013-11-13 | $1.98M derived: sum of 2 quarters · filed 2013-11-13 | $5.50M 10-Q · filed 2013-11-13 | $10.28M derived: sum of 4 quarters · filed 2014-03-27 | |||
| 2012-06-30 | $679.00K 10-Q · filed 2013-08-13 | $4.10M 10-Q · filed 2013-08-13 | $8.98M derived: sum of 3 quarters · filed 2014-03-27 | $10.68M derived: sum of 4 quarters · filed 2014-03-27 | |||
| 2012-03-31 | $3.40M 10-Q · filed 2013-05-10 | $8.30M derived: sum of 2 quarters · filed 2014-03-27 | $10.00M derived: sum of 3 quarters · filed 2014-03-27 | $10.55M derived: sum of 4 quarters · filed 2014-03-27 | |||
| 2011-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $6.60M derived: sum of 2 quarters · filed 2014-03-27 | $7.16M derived: sum of 3 quarters · filed 2014-03-27 | $8.80M 10-K · filed 2014-03-27 | |||
| 2011-09-30 | $1.70M 10-Q · filed 2012-11-14 | $2.25M derived: sum of 2 quarters · filed 2012-11-14 | $3.90M 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $555.00K 10-Q · filed 2012-08-13 | $2.20M 10-Q · filed 2012-08-13 | |||||
| 2010-12-31 | $6.90M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |